Cansortium Announces Opening of its 22nd Fluent™ Medical Marijuana Dispensary in Florida
Cansortium Inc. has expanded its operations in Florida by opening its 22nd dispensary in Coral Gables on October 14, marking the fourth in 2020. The new location enhances Fluent's presence in Miami-Dade County, following dispensaries in Cutler Bay and North Miami Beach. This launch coincides with the introduction of Fluent Gels, the company's first edibles line, with over 1,100 units sold on the first day. Cansortium aims to open three more dispensaries by year-end, furthering its commitment to premium cannabis products in Florida.
- Opened 22nd dispensary in Florida, Coral Gables, enhancing market reach.
- Launch of Fluent Gels coincided with dispensary opening, boosting initial sales.
- Plans to expand with three more dispensaries by the end of 2020.
- None.
MIAMI, Oct. 15, 2020 /PRNewswire/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE: TIUM.U), (OTCQB: CNTMF) a vertically-integrated provider of premium-quality medical cannabis operating under the Fluent™ brand, continues its Florida expansion with the October 14th opening of its 22nd Florida dispensary; making it the fourth of 2020.
The Company's newest dispensary is located in Coral Gables at 5827 SW 40th St, Miami, FL, 33155, just off the Palmetto Highway and down Bird Road. Tucked away minutes from downtown, The City of Coral Gables is an international-business hub with an abundance of old-world charm and lush greenery that surrounds. Its many fountains, plazas, and picturesque corners create the ideal setting for its many chic cafes and fine-dining options. Coral Gables' latest dispensary makes it Fluent's third location in Miami-Dade County, after Cutler Bay and North Miami Beach.
Cansortium's Chief Executive Officer, Robert Beasley, remarked, "I love the look and feel of this new store! We are on track to open three more dispensaries in Florida by the end of 2020." The Coral Gables opening coincides with the launch of the Company's new Fluent Gels product line, following the State of Florida's recent approval of edibles as another route for medicinal cannabis. Fluent Gels are the first edibles product on offer at Fluent. Mr. Beasley further commented, "The Coral Gables opening was perfect timing as edibles come into the market." The dispensary had a strong opening day that coincided with Company-wide sales of over 1,100 units of Fluent Gels on their first full day of availability.
The Fluent brand continually strives to set the standard for premium quality, consistently formulated cannabis products. Each of the Company's Florida dispensaries carries a wide assortment of Fluent premium dried flower, edibles and full-spectrum concentrates and cartridges as well as creams, drops, capsules, and suppositories. All Fluent products in the Company's Florida dispensaries use high-quality cannabis that is cultivated, processed, and packaged in the Company's Florida facility in strict compliance with Florida regulations. For consumers, the sleek, modern dispensaries provide a warm, welcoming, professional environment, with private consultation rooms and knowledgeable staff who carefully guide patients in selecting the right products and carefully safeguard patient privacy.
For a complete list of Fluent dispensary locations, current promotions and rewards programs and hours of operation, or to explore the entire Fluent product line and place an online order for home delivery anywhere in Florida, visit https://getfluent.com/.
About Cansortium Inc.
Headquartered in Miami, Florida, and operating under the Fluent™ brand, Cansortium is focused on being the highest quality cannabis company in the State of Florida driven by an unrelenting commitment to operational excellence from seed to sale. Cansortium has developed strong proficiencies in each of cultivation, processing, retail, and distribution activities, resulting in successfully operating in the highly regulated cannabis industry. In addition to Florida, Cansortium seeks to create significant shareholder value in the attractive markets of Texas, Michigan, and Pennsylvania, where the Company has secured licenses and established operations.
Cansortium Inc.'s common shares and warrants trade on the CSE under the symbol "TIUM.U" and "TIUM.WT.U", respectively, and on the OTCQB Venture Market under the symbol (OTCQB: CNTMF). Investors can find current financial disclosure and Real-Time Level 2 quotes for the Company on www.otcmarkets.com.
Forward-Looking Information
Certain information in this news release may constitute forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates, and projections regarding future events.
Forward-looking information is necessarily based on many opinions, assumptions, and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in the public documents of the Company available at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
View original content to download multimedia:http://www.prnewswire.com/news-releases/cansortium-announces-opening-of-its-22nd-fluent-medical-marijuana-dispensary-in-florida-301153206.html
SOURCE Cansortium Inc
